As a result of the ongoing coronavirus (Covid-19) pandemic, individuals and governments around the world are undertaking very costly actions to prevent the rapid spread of the disease and potentially millions of deaths (e.g. social distancing interventions resulting in sharp decreases in economic activity and asset values). This situation creates an ideal natural experiment to … Continue reading Willingness to pay for morbidity and mortality risk reductions during an epidemic. Theory and preliminary evidence from the Covid-19 epidemic